US to impose 100% tariffs on branded, patented pharma drugs from October 1 unless made in US Major Indian firms like Cipla, Dr Reddys, and Biocon have US manufacturing, likely avoiding tariffs Sun Pharma may be affected by tariffs until it reveals US investment plans
